Casa de Saúde Santa Marcelina

São Paulo 08270-120

1 studies enrolling now · 4 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Cancer, Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Iron Overload, Myelodysplastic Syndromes (MDS), Other Anemias, Sickle Cell Disease, Vaso-occlusive Crisis, Vaso-occlusive Pain Episode in Sickle Cell Disease

Studies at this site

• Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation — Recruiting now
• A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises — Completed
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias — Stopped early